Fresenius USA Marketing, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$4.8Mgeneral payments (2019-2025)
$3,000research payments (2019-2025)
7,867clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.1M
2020 $420K
2021 $530K
2022 $823K
2023 $748K
2024 $709K
2025 $455K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Nephrology (Internal Medicine) $3.4M
Family $294K
Gerontology (Nurse Practitioner) $220K
Nurse Practitioner $219K
Internal Medicine $104K
Acute Care (Nurse Practitioner) $86K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Moustafa Moustafa Orangeburg, SC Nephrology (Internal Medicine) $540,109.67
Anjay Rastogi Los Angeles, CA Nephrology (Internal Medicine) $264,659.24
Flavius Nascimento Coral Springs, FL Gerontology (Nurse Practitioner) $212,687.18
Rodolfo Batarse Rancho Mirage, CA Nephrology (Internal Medicine) $128,203.08
Luis Alvarez Palo Alto, CA Nephrology (Internal Medicine) $123,591.45
Daniel Coyne Saint Louis, MO Nephrology (Internal Medicine) $67,610.78
Precious Hodges Lafayette, LA Acute Care (Nurse Practitioner) $64,021.86
Kimi Prentice Ewa Beach, HI Nurse Practitioner $63,900.03
James Mccabe Wilmington, NC Nephrology (Internal Medicine) $55,658.05
Marcos Rothstein Saint Louis, MO Nephrology (Internal Medicine) $53,957.01

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.